UK to add India’s Covaxin to approved list

The UK government has said that India’s Covaxin will be added to its list of approved Covid-19 vaccines for international travellers from November 22, meaning that those inoculated with the Bharat Biotech-manufactured jab will not have to self-isolate after arrival in England. Continue Reading

Bharat Biotech terminates MoU with Brazilian partners

Bharat Biotech on Friday said it terminated the Memorandum of Understanding entered with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its Covid-19 vaccine Covaxin for the Brazilian market. Continue Reading

From today, AIIMS Delhi to start screening children for Covaxin trials

The All India Institute of Medical Sciences (AIIMS) Delhi will today start screening children for the clinical trials of Covaxin, the indigenous Covid-19 vaccine developed by Bharat Biotech and ICMR. Continue Reading

Serum to raise monthly production to 10 cr doses by August

Amid multiple states reporting a shortage of Covid-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively by August, official sources said on Wednesday. Continue Reading

Vaccination drive: India fastest country to reach one million mark

A week into kickstarting its inoculation programme, India has managed to vaccinate almost 16 lakh people. Continue Reading

Centre issues purchase orders for Covishield & Covaxin

The government of India on Monday issued purchase orders to Serum Institute of India and Bharat Biotech for their respective Covid-19 vaccines. Continue Reading

All eyes on India’s anti-Covid drive

The Central Drugs and Standards Committee (CDSCO) on Sunday formally approved the Covid-19 vaccines by Bharat Biotech and the Serum Institute of India (SII). Continue Reading